🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Vendors market the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.

Some professionals stated the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking fines, prosecution or prison.

Service Reaction and Content Elimination

Based on TikTok, the platform has taken down violative content and prohibited associated keywords and search suggestions. The company said it was committed to keeping the service safe and investing in strengthening compliance measures.

Online Trading Operations

Research also found communities with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, positive reviews and detailed instructions for preparing or injecting at home.

After minutes of entering one group, a seller posted contact information, where most transactions occur. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.

Product Information and Pricing

Inside these groups, posts show dark colored packages with postal service labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram said it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously seen patients injured by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious health risks”.